|
Volumn 37, Issue 2, 2005, Pages 1220-1223
|
Nephrotoxic effects of immunosuppressant therapy in pediatric liver transplant recipients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE;
ANTIHYPERTENSIVE AGENT;
AZATHIOPRINE;
CALCINEURIN INHIBITOR;
CALCIUM CHANNEL BLOCKING AGENT;
CHROMIUM 51;
CYCLOSPORIN A;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
EDETIC ACID;
ENALAPRIL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IMMUNOSUPPRESSIVE AGENT;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PURINE ANTAGONIST;
RADIOISOTOPE;
TACROLIMUS;
ADOLESCENT;
CHILD;
CHOLESTEROL BLOOD LEVEL;
CLINICAL ARTICLE;
CONFERENCE PAPER;
FEMALE;
GLOMERULUS FILTRATION RATE;
GLUCOSE BLOOD LEVEL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFANT;
KIDNEY FUNCTION;
LIPID BLOOD LEVEL;
LIVER GRAFT REJECTION;
LIVER TRANSPLANTATION;
LYMPHOPROLIFERATIVE DISEASE;
MALE;
NEPHROTOXICITY;
PEDIATRIC SURGERY;
PRIORITY JOURNAL;
SIDE EFFECT;
|
EID: 17844375693
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.12.223 Document Type: Conference Paper |
Times cited : (9)
|
References (11)
|